Monument Health

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Heart failure4 trials
• Coronary artery disease1 trial

Phase

• Phase 32 trials

Status

• Recruiting3 trials
• Completed1 trial

Lead sponsor

• Alleviant Medical, Inc.2 trials
• Boehringer Ingelheim2 trials

Running trials

• Recruiting

  Alleviant ALLAY-HFrEF Study

  NCT06812533· Alleviant Medical, Inc.· Source

  Contact: Luis Hernandez, MD (principal investigator)

• Recruiting

  A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

  NCT06424288· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Recruiting

  Alleviant ALLAY-HF Study

  NCT05685303· Alleviant Medical, Inc.· Source

  Contact: K John Heilman III, MD (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Heart failure3 recruiting

Closed trials

• Completed

  EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)

  NCT04509674· Phase 3· Boehringer Ingelheim· Source